To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
The mechanisms of pharmaceutical rebates in Medicare Part D and commercial insurance.
Millions of Americans are seeing the cost of their medications go up. But what you might not know is that even as they rake in record profits, drug companies are getting two bites out of our pocketbook.
Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs.